Furthermore, additional work will be necessary to establish the extent to which SCARNA15 post-transcriptionally contributes to MYC-induced spliceosome remodelling in cancer cells (71,72), which has been recently shown to converge on a central hub of splicing factors associated with U2 snRNP (37). This evidence concerns the gene MYC and cancer.